FDA OKs label changes to boost CAR T-cell therapy use for cancer
The U.S. Food and Drug Administration (FDA) has approved…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
The art of distraction: Why sometimes we avoid ‘cancer talk’
There is an unspoken rule that seems to apply…
Lynozyfic wins FDA accelerated approval for treating RRMM adults
Linvoseltamab, now branded as Lynozyfic, has received accelerated approval…
Recognizing the invisible labor we perform as caregivers
I have 27 browser tabs open on my laptop…
EU panel backs 1st-line Sarclisa for transplant-eligible myeloma
A European Medicines Agency committee has recommended that…
As a caregiver, I’m always on the lookout for myeloma research news
The word “caregiver” usually conjures up images of hands-on…
